Search

Your search keyword '"Czene K."' showing total 51 results

Search Constraints

Start Over You searched for: Author "Czene K." Remove constraint Author: "Czene K." Topic humans Remove constraint Topic: humans
51 results on '"Czene K."'

Search Results

1. PredictCBC-2.0: a contralateral breast cancer risk prediction model developed and validated in ~ 200,000 patients

2. Breast cancer risks associated with missense variants in breast cancer susceptibility genes

3. Breast Cancer Risk Genes — Association Analysis in More than 113,000 Women

4. Functional annotation of the 2q35 breast cancer risk locus implicates a structural variant in influencing activity of a long-range enhancer element

5. Mendelian randomisation study of smoking exposure in relation to breast cancer risk

6. Common variants in breast cancer risk loci predispose to distinct tumor subtypes

7. Assessment of interactions between 205 breast cancer susceptibility loci and 13 established risk factors in relation to breast cancer risk, in the Breast Cancer Association Consortium

8. Fine-mapping of 150 breast cancer risk regions identifies 191 likely target genes

9. Two truncating variants in FANCC and breast cancer risk

10. Prevalence of BRCA1 and BRCA2 pathogenic variants in a large, unselected breast cancer cohort

11. Polygenic Risk Scores for Prediction of Breast Cancer and Breast Cancer Subtypes

12. DNA mismatch repair gene MSH6 implicated in determining age at natural menopause

13. The BRCA2 c.68-7T > A variant is not pathogenic: A model for clinical calibration of spliceogenicity

14. Gene-environment interactions involving functional variants

15. Intratumor Heterogeneity of the Estrogen Receptor and the Long-term Risk of Fatal Breast Cancer

16. Body mass index and breast cancer survival: a Mendelian randomization analysis

17. Genetic variation in mitotic regulatory pathway genes is associated with breast tumor grade

18. rs2735383, located at a microRNA binding site in the 3'UTR of NBS1, is not associated with breast cancer risk

19. Evidence that the 5p12 Variant rs10941679 Confers Susceptibility to Estrogen-Receptor-Positive Breast Cancer through FGF10 and MRPS30 Regulation

20. Identification and characterization of novel associations in the CASP8/ALS2CR12 region on chromosome 2 with breast cancer risk

21. Five endometrial cancer risk loci identified through genome-wide association analysis

22. Genetic predisposition to ductal carcinoma in situ of the breast

23. BRCA2 polymorphic stop codon K3326X and the risk of breast, prostate, and ovarian cancers

24. SNP-SNP interaction analysis of NF-kappa B signaling pathway on breast cancer survival

25. No evidence that protein truncating variants in BRIP1 are associated with breast cancer risk: implications for gene panel testing

26. Prediction of Breast Cancer Risk Based on Profiling With Common Genetic Variants

27. Identification of novel genetic markers of breast cancer survival

28. Fine-mapping of the HNF1B multicancer locus identifies candidate variants that mediate endometrial cancer risk

29. Fine-mapping identifies two additional breast cancer susceptibility loci at 9q31.2

30. Candidate locus analysis of the TERT-CLPTM1L cancer risk region on chromosome 5p15 identifies multiple independent variants associated with endometrial cancer risk

31. Meta-analysis of genome-wide association studies identifies common susceptibility polymorphisms for colorectal and endometrial cancer near SH2B3 and TSHZ1

32. Identification of Novel Genetic Markers of Breast Cancer Survival

33. Common non-synonymous SNPs associated with breast cancer susceptibility: findings from the Breast Cancer Association Consortium

34. Investigation of gene-environment interactions between 47 newly identified breast cancer susceptibility loci and environmental risk factors

35. A large-scale assessment of two-way SNP interactions in breast cancer susceptibility using 46,450 cases and 42,461 controls from the breast cancer association consortium

36. MicroRNA related polymorphisms and breast cancer risk

37. Large-scale genotyping identifies 41 new loci associated with breast cancer risk

38. Association Between a Germline OCA2 Polymorphism at Chromosome 15q13.1 and Estrogen Receptor-Negative Breast Cancer Survival

39. Assessment of variation in immunosuppressive pathway genes reveals TGFBR2 to be associated with prognosis of estrogen receptor-negative breast cancer after chemotherapy

40. rs2735383, located at a microRNA binding site in the 3'UTR of NBS1, is not associated with breast cancer risk

41. Functional mechanisms underlying pleiotropic risk alleles at the 19p13.1 breast-ovarian cancer susceptibility locus

42. Age- and Tumor Subtype-Specific Breast Cancer Risk Estimates for CHEK2*1100delC Carriers

43. Identification of four novel susceptibility loci for oestrogen receptor negative breast cancer

44. Time-dependent risk of developing distant metastasis in breast cancer patients according to treatment, age and tumour characteristics

45. A unified model for estimating and testing familial aggregation

46. The HLA-DQβ1 insertion is a strong achalasia risk factor and displays a geospatial north-south gradient among Europeans

47. Patterns of changing cancer risks with time since diagnosis of a sibling

48. High risks of familial chronic lymphatic leukemia for specific relatives: signposts for genetic discovery?

49. Prognosis of patients with breast cancer: causes of death and effects of time since diagnosis, age, and tumor characteristics

50. Are chronic myeloid leukemia patients more at risk for second malignancies? A population-based study

Catalog

Books, media, physical & digital resources